课题基金 / 基金详情

Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease

Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease
心率动态对上肢功能测试的反应,以识别患有晚期心脏病的老年人在侵入性治疗后的不可逆转的虚弱
批准号:
10582957
负责人:
Nima Toosizadeh
金额:
$1.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-15 至 2023-06-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Advanced heart diseases lead to a reduced blood supply from the heart and consequently fatigue and deficits in performing physical activity. In the proposed research, we will assess the lack of physiological reserve in older adults with advanced heart disease, focusing on motor and cardiac function, to develop a novel, objective, quick, and accurate frailty score. We designed this approach to enhance candidate selection of older adults going through invasive therapies for advanced heart diseases. Although our approach is generic, to reduce between- subject variability we focus on transcatheter aortic valve replacement (TAVR) for older adult with aortic stenosis. Therapeutic options continue to grow for TAVR; however, it can be difficult to identify candidates with frailty level that prohibit them from tolerating the stress from aggressive therapy and those with potential reversible frailty. It is thus critically important to introduce meaningful routine objective frailty assessment into clinical care of cardiac patients. Frailty assessment is, however, not common in cardiology because current assessment tools are burdensome for older adults with advanced heart disease and impractical to implement in busy clinical environments. More importantly, no disease-specific tool is available to identify heart disease-related frailty. In continuation of our research program in the field of sensor-based frailty assessment, within our multidisciplinary team of engineers, cardiologists, and geriatricians, we propose the multimodal upper-extremity function (UEF) test for identifying frailty among older adults with advanced heart disease. UEF incorporates a synchronized system of motion sensors and electrocardiography (ECG) to measure motor performance and heart rate (HR) during a rapid 20-second elbow flexion task. Using our previously established UEF motion tracking component, we can precisely measure the level of deficits in motor performance (slowness, weakness, inflexibility, and fatigue), which are not detectable using eyeball assessment. Using the ECG setup, minimizing the motion artifact using this localized task, we accurately track HR response to the physical demand, as well as recovery behavior after the task. HR behavior during the task and recovery (HR dynamics) provide a measure of cardiac reserve associated with frailty in heart disease. We will further quantify dysregulation between HR response and motor demand as a novel measure of resilience. Based on our preliminary data, we expect a weaker and delayed HR response to physical activity as well as an impaired motor function due to frailty. The proposed research will be a four-year study at the University of Arizona Cardiovascular program. In the first arm, we will establish a new HR score and merge it with our previously validated UEF motor score to develop a multimodal frailty score among older adults with advanced heart disease (n=120). In the second arm, in a longitudinally setting we will validate the UEF multimodal frailty score for predicting TAVR complications for advanced heart disease (n=75). Accomplishing these aims, we will promote HR dynamic assessment for risk stratification of older adults with advanced heart disease, with huge potentials for other comorbid conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: